{"filing":{"accession_number":"0000825542-26-000032","cik":"0000825542","ticker":"SMG","company_name":"SCOTTS MIRACLE-GRO CO","form":"8-K","filing_date":"2026-07-01","report_date":null,"primary_document":"smg-20260701.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/825542/000082554226000032/smg-20260701.htm"},"events":[{"id":15455,"run_id":13786,"accession_number":"0000825542-26-000032","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Nathan E. Baxter was appointed President \u0026 Chief Executive Officer effective June 26, 2026, and elected to the Board of Directors. While the filing also discloses James Hagedorn's departure as CEO and Chairman (and his severance arrangements), the principal disclosed action centers on Baxter's appointment to the top executive role and board seat, which is the forward-looking leadership change. The appointment is material as it represents a significant succession event at the company's helm after Hagedorn's 25-year tenure as CEO.","company_name":"SCOTTS MIRACLE-GRO CO","ticker":"SMG","filing_date":"2026-07-01","form":"8-K","submitted_at":null,"items":[{"id":13228,"accession_number":"0000825542-26-000032","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Nathan E. Baxter was appointed President \u0026 Chief Executive Officer effective June 26, 2026, and elected to the Board of Directors. While the filing also discloses James Hagedorn's departure as CEO and Chairman (and his severance arrangements), the principal disclosed action centers on Baxter's appointment to the top executive role and board seat, which is the forward-looking leadership change. The appointment is material as it represents a significant succession event at the company's helm after Hagedorn's 25-year tenure as CEO.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T20:05:42.160062+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13228,"accession_number":"0000825542-26-000032","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Nathan E. Baxter was appointed President \u0026 Chief Executive Officer effective June 26, 2026, and elected to the Board of Directors. While the filing also discloses James Hagedorn's departure as CEO and Chairman (and his severance arrangements), the principal disclosed action centers on Baxter's appointment to the top executive role and board seat, which is the forward-looking leadership change. The appointment is material as it represents a significant succession event at the company's helm after Hagedorn's 25-year tenure as CEO.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T20:05:42.160062+00:00","company_name":"SCOTTS MIRACLE-GRO CO","ticker":"SMG","filing_date":"2026-07-01"}]}